CDK9-IN-15
CDK9-IN-15 is a potent and selective CDK9 inhibitor that induces tumor cell apoptosis by blocking P-TEFb-mediated RNA Polymerase II phosphorylation, leading to rapid mRNA depletion. It is a valuable chemical probe for studying transcriptional regulation in oncology research, demonstrating activity in both cellular and in vivo models of cancer.
Product Specifications
CAS Number
852678-17-2
Product Name Alternative
CDK9
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
97.24% (May vary between batches)
Solubility
DMSO:112.5 mg/mL (383.51 mM) ;10% DMSO+90% Saline:3.3 mg/mL (11.25 mM)
Smiles
Oc1cccc2c (Nc3ncnc4sccc34) cccc12
Molecular Formula
C16H11N3OS
Molecular Weight
293.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15290260 1 Vial
Lentiviral human ATP5MPL shRNA (UAS) - Lentiviral human ATP5MPL shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
MBS2031024-01 0.01 mg
Recombinant Cluster Of Differentiation 276 (CD276)
Sign In for Pricing
View Details 
MBS2031024-02 0.05 mg
Recombinant Cluster Of Differentiation 276 (CD276)
Sign In for Pricing
View Details MBS2031024-03 0.1 mg
Recombinant Cluster Of Differentiation 276 (CD276)
Sign In for Pricing
View Details MBS2031024-04 0.2 mg
Recombinant Cluster Of Differentiation 276 (CD276)
Sign In for Pricing
View Details